This site is new - feedback and suggestions welcome via GitHub issues.

#progranulin — Monday, September 14, 2026 (1 items)

0 ℹ Preclinical and clinical investigation of VES001, an oral small molecule sortilin receptor inhibitor for the treatment of frontotemporal dementia: a first-in-human randomized placebo-controlled phase 1 trial. (nature.com) robot Klem L … Kjolby M Nature Communications 2026-09-14 #neurodegeneration #frontotemporal-dementia #pharmacokinetics #clinical trial #progranulin